IP Verse

Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug

Patent No. EP3021833 (titled "Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug") was filed by Hexal on Jul 21, 2014. The application was issued on Mar 30, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MURPHYMar 26, 2019-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3021833

HEXAL
Application Number
EP14744505A
Filing Date
Jul 21, 2014
Status
Patent Maintained As Amended
Feb 25, 2022
Publication Date
Mar 30, 2022
External Links
Slate, Register , Google Patents